HCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI™ Platform

December 7, 2022

https://www.globenewswire.com/news-release/2022/12/07/2569184/0/en/HCW-Biologics-is-Granted-Second-Fundamental-Patent-U-S-Patent-for-Multi-Chain-Chimeric-Polypeptide-Created-with-TOBI-Platform.html

Allowed Claims for Novel Immunotherapeutic Compound Constructed with Tissue Factor as Platform for Target Binding Domains

Patent for Underlying Intellectual Property for HCW9218 Currently in Clinical Development for Cancer

Read more at globenewswire.com

Related news for (HCWB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.